GoKawiilEnsitrelvir has already been approved as a prophylactic in Japan, with an FDA decision in the U.S. expected soon.
No Pill Currently Prevents Covid-19. This One Just Might
Why This Matters
The approval of Ensitrelvir as a prophylactic for Covid-19 marks a significant advancement in pandemic prevention, potentially offering an accessible oral treatment to reduce infection rates. Its upcoming FDA decision could influence global strategies for managing Covid-19 and future pandemics. This development underscores the ongoing innovation in antiviral therapies that could reshape public health responses.
Key Takeaways
- Ensitrelvir is approved in Japan as a Covid-19 prophylactic.
- An FDA decision in the U.S. is anticipated soon.
- This could lead to new oral treatments to prevent Covid-19 infections.
Get alerts for these topics